adult ADHD

Centanafadine: New Hope for Adult ADHD?

by

Novel non-Stimulant Shows Promise for Adult ADHD: Centanafadine Demonstrates Clinically Meaningful Enhancement Table of Contents Novel non-Stimulant Shows Promise for Adult ADHD: Centanafadine Demonstrates Clinically Meaningful Enhancement Centanafadine Shows Promise in ADHD Treatment: A New Approach to Symptom Management Understanding Centanafadine’s Impact on ADHD Symptoms Expanding the Research: Pediatric Trials Yield Positive Results safety Profile … Read more

Centanafadine ‘Clinically Meaningful’ for Adult ADHD

by

LOS ANGELES — The novel norepinephrine, dopamine, and serotonin reuptake inhibitor (NDSRI) centanafadine (Otsuka Pharmaceutical Co., Ltd.) is effective and “clinically meaningful” for adult attention-deficit/hyperactivity disorder (ADHD), new research suggested. In a combined analysis of two phase 3 trials with a total of 859 adults, more patients who received the NDSRI had at least an … Read more

Study finds adults with ADHD may lose up to 9 years of life expectancy

by

A new study published in The British Journal of Psychiatry revealed that adults with Attention Deficit Hyperactivity Disorder (ADHD) may have a reduced life expectancy compared to those without the condition. The research found that men with ADHD lose an average of 6.78 to 7 years of life, while women lose between 8.64 and … Read more